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At the recent International Hepato-Pancreato-Biliary Associa-
tion (IHPBA) world congress in Buenos Aires, numerous
presentations1–11 addressed various aspects of single-port access or
natural orifice endoscopic cholecystectomy. The largest series is of
particular importance in that this study of 106 patients undergo-
ing single-port cholecystectomy reported a bile duct injury.1 Sur-
prisingly, the authors’ conclusions are similar to those of authors
reporting other smaller series: namely, that this procedure is
safe.1,4,5
These reports raise a number of issues. Patient selection was not
often apparent, but it seemed evident that only uncomplicated
gallbladder disease was reported. Several variations in technique
were described, which suggests a lack of standardization; varia-
tions included differences in access points and instruments used.
Lawenko et al.4 compared seven patients undergoing single-port
cholecystectomy with an identical number undergoing conven-
tional laparoscopic cholecystectomy. Operating time in the former
was almost twice that of the standard procedure (114 min vs.
68 min; P = 0.001) and there was no difference in hospital stay. You
et al.1 have, however, shown a learning curve with this procedure
and so this difference in operating time may diminish as experi-
ence accumulates. Chang et al.3 performed a similar comparative
study and measured outcomes in terms of pain and time taken to
return to normal activities. They found no difference in pain
scores, but the single-port group returned to work 1.7 days earlier.
However, in many other countries, this type of elective surgery is
undertaken on a day case basis and it seems unreasonable to use
length of hospital stay or return to work as outcome measures.
Interestingly, these studies made no objective assessment of
cosmetic outcome, which would seem to be one of the prime
considerations in the decision to submit to the procedure.
These studies raise several critical issues for the profession
of surgery. It is almost three decades since the ad hoc introduction
of laparoscopic cholecystectomy into surgical practice led to a
significant increase in bile duct injuries.12–16 This is a devastating
complication for patient, society and surgeon. In particular, the
patient pays a huge price in terms of both quality and duration of
life, with an average reduction in life expectancy of 9 years.17
Although the incidence of bile duct injury may be considered low,
Flum et al.17 reported rates as high as one in 200 patients under-
going cholecystectomy (7911 in 1 570 361 procedures); thus, the
prevalence is high given the frequency with which cholecystec-
tomy is performed. Thus, any subtle change to the underlying
incidence can have significant effects on its prevalence.
There is an onus on the surgical profession to ensure that any
new procedures are introduced in such a way that patients are not
put at increased risk for serious complications. Large series will
struggle to determine the safety of these new techniques, given the
low incidence of bile duct injury. Furthermore, randomized trials
will need to include so many patients that the costs and prac-
ticalities of performing such studies will prove prohibitive.
However, alternative strategies exist, such as the establishing of a
mandatory national or international database to which statistical
process control methodology could be applied.18 Thus, rather than
measuring the incidence of bile duct injury (when disaster has
already occurred), a safety checklist can be designed to ensure the
critical view19 is achieved safely by establishing a set of criteria
to be fulfilled. Any decrease in frequency with which this was
achieved could subsequently be detected prior to an increase in
the incidence of bile duct injury. Ferreres et al.2 have adopted a
similar approach and should be congratulated on their efforts.
They describe 60 single-incision laparoscopic cholecystectomies
in which the procedure was recorded and reviewed by indepen-
dent observers. The primary endpoint was safe dissection and
display of the critical view within Calot’s triangle. Of the 60
patients reported, the critical view was obtained in 55 (91.7%)
patients. This demonstration that the critical view can be attained
is paramount to the safe introduction of this technique and the
prevention of bile duct injuries. Modern technology and the cre-
ation of web-based repositories for the submission of recorded
procedures would allow for the subsequent review and assessment
of predefined criteria by independent observers.
So who is responsible for regulating the introduction of this
new technology? Several institutions, bodies and professional
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societies may need to consider their role in ensuring that new
technology is rolled out safely. Should industry ensure that new
technologies are safe by mandating the compulsory reporting of
predetermined outcomes to be overseen by independent data
assessment committees? Should ethical committees ensure that
adequate consideration has been given to both the power of
studies and the proposed primary endpoint such that meaningful
interpretation of results is possible?
Given that the apparent benefit of this new technique would
seem to be only cosmetic, it is important that patients are aware of
what a small increase in the risk for bile duct injury implies and
what the likely benefit of the new procedure actually is. Therefore,
do prospective investigators need to reflect on how they intend to
obtain informed consent from patients for small studies?
An IHPBA position statement on how the development of this
technology should be introduced and monitored should also be
given consideration. Failure to address this issue risks the credibil-
ity of the profession with the public if history is repeated.
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